Clinical Studies

Jum directly to navigation / Zur Navigation springen

Alzheimer's disease

Atherosclerosis

The proprietor of this website is processing the personal data as a trustee for AFFiRiS AG, Karl-Farkas-Gasse 22, 1030 Vienna


Alzheimer's disease

Two Alzheimer vaccines are currently developed by AFFiRiS, AFFITOP AD01 and AFFITOP AD02. The second is now entering the second stage of clinical testing.

|

I consider participation in phase 2 study of AFFITOP AD02

Atherosclerosis

 

 

 

 

In preparation